Login

Trammell Crow Expands Biotech Portfolio With Deal for Silicon Valley Development Site

CBRE Subsidiary's New Life Science Project Slated To Replace Redwood City, California, Office Property
Trammell Crow will move forward with the redevelopment of a site at 200 Twin Dolphin Drive in Redwood City, California, into a life science campus. (Trammell Crow)
Trammell Crow will move forward with the redevelopment of a site at 200 Twin Dolphin Drive in Redwood City, California, into a life science campus. (Trammell Crow)
CoStar News
January 25, 2022 | 12:32 AM

Trammell Crow is doubling down on its bet on the national biotech market with the $65 million purchase of a Silicon Valley site slated for a research and development project.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

News | Trammell Crow Expands Biotech Portfolio With Deal for Silicon Valley Development Site